Don't miss these events!
Product availability may vary from country to country and is subject to varying regulatory requirements. Please contact your local representative for availability. The outcomes obtained by the Siemens Healthineers customer described here were realized in the customer’s unique setting. Since there is no typical laboratory, and many variables exist, there can be no guarantee that others will achieve the same results.
CLINITEK, CLINITEK Status, DCA Vantage, POC Ecosystem and all associated marks are trademarks of Siemens Healthcare Diagnostics Inc., or its affiliates.
Knights H, Mayor N, Millar K, et al. Characteristics and outcomes of patients with COVID-19 at a district general hospital in Surrey, UK. Clinical Medicine. 2020 Sep;20(5).
Rovere-Querini P, De Lorenzo R, Conte C, et al. Post-COVID-19 follow-up clinic: depicting chronicity of a new disease. Acta Biomed. 2020;91(Suppl 9):22-8.
Wang Z, Du Z, Zhu F. Glycosylated hemoglobin is associated with systemic inflammation, hypercoagulability, and prognosis of COVID-19 patients.
Zhou F, Yu T, Du R, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. 2020;395;1054-62.
Lenters-Westra E, Slingerland RJ. Clin Chem 2010;56(1):44.
Thaler LM, et al. Diabetes Care 1999;22:1415-21.
Miller CD, et al. Diabetes Care 2003;26:1158-63.
Cagliero E, et al. Diabetes Care 1999;22:1785-9.